Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immune System Diseases × Lutetium-177 × Clear all

Sponsor

Conditions

Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Neoplasm Metastasis 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

Rituximab 4 Cyclophosphamide 3 ponatinib 2 Vorinostat 2 Vincristine 2 Prednisone 2 Etoposide 2 Doxorubicin 2 Brentuximab Vedotin 2 Bortezomib 2 tetulomab tetraxetan lu-177 1 ibrutinib 1 ibritumomab tiuxetan 1 fludarabine 1 durvalumab 1 cobomarsen 1 acalabrutinib 1 Melphalan 1 Lutetium 1 Lenalidomide 1 KW-2478 1 Imatinib Mesylate 1 Ifosfamide 1 Hsp90 inhibitor KU757 1 Cytarabine 1 Carmustine 1 Carboplatin 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡